KALA
KALA BIO, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.51
−9.57%Aug 28, 2026, 00:00 UTC
KALA BIO, Inc. received a notice from NASDAQ on August 27, 2026, stating that it is not in compliance with Listing Rule 5550(a)(2) regarding the minimum bid price requirement, and the company has requested a hearing before a NASDAQ panel.